BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30135508)

  • 41. Differential role of gene hypermethylation in adenocarcinomas, squamous cell carcinomas and cervical intraepithelial lesions of the uterine cervix.
    Blanco-Luquin I; Guarch R; Ojer A; Pérez-Janices N; Martín-Sánchez E; Maria-Ruiz S; Monreal-Santesteban I; Blanco-Fernandez L; Pernaut-Leza E; Escors D; Guerrero-Setas D
    Pathol Int; 2015 Sep; 65(9):476-85. PubMed ID: 26222671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study.
    Bonde J; Floore A; Ejegod D; Vink FJ; Hesselink A; van de Ven PM; Valenčak AO; Pedersen H; Doorn S; Quint WG; Petry KU; Poljak M; Stanczuk G; Cuschieri K; de Sanjosé S; Bleeker M; Berkhof J; Meijer CJLM; Heideman DAM
    Int J Cancer; 2021 Jan; 148(2):396-405. PubMed ID: 32997803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
    Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
    Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
    Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
    Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
    [No Abstract]   [Full Text] [Related]  

  • 45. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
    Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
    Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women.
    Fiano V; Trevisan M; Fasanelli F; Grasso C; Marabese F; da Graça Bicalho M; de Carvalho NS; Maestri CA; Merletti F; Sacerdote C; De Marco L; Gillio-Tos A
    Gynecol Oncol; 2018 Nov; 151(2):319-326. PubMed ID: 30172480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential DNA copy number aberrations in the progression of cervical lesions to invasive cervical carcinoma.
    Oh EK; Kim YW; Kim IW; Liu HB; Lee KH; Chun HJ; Park DC; Oh EJ; Lee AW; Bae SM; Ahn WS
    Int J Oncol; 2012 Dec; 41(6):2038-46. PubMed ID: 23023522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.
    Kremer WW; van Zummeren M; Heideman DAM; Lissenberg-Witte BI; Snijders PJF; Steenbergen RDM; Dreyer G; Meijer CJLM
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30360578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis.
    Flatley JE; McNeir K; Balasubramani L; Tidy J; Stuart EL; Young TA; Powers HJ
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2782-9. PubMed ID: 19755648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of
    Kremer WW; Dick S; Heideman DAM; Steenbergen RDM; Bleeker MCG; Verhoeve HR; van Baal WM; van Trommel N; Kenter GG; Meijer CJLM; Berkhof J
    J Clin Oncol; 2022 Sep; 40(26):3037-3046. PubMed ID: 35512257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status.
    Hublarova P; Hrstka R; Rotterova P; Rotter L; Coupkova M; Badal V; Nenutil R; Vojtesek B
    Int J Gynecol Cancer; 2009 Apr; 19(3):321-5. PubMed ID: 19407553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistological analysis of HPV L1 capsid protein and p16 protein in low-grade dysplastic lesions of the uterine cervix.
    Hoshikawa S; Sano T; Yoshida T; Ito H; Oyama T; Fukuda T
    Pathol Res Pract; 2010 Dec; 206(12):816-20. PubMed ID: 20965668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
    Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of HPV E4 and p16
    Damgaard RK; Jenkins D; de Koning MN; Quint WG; Stoler MH; Doorbar J; Kahlert J; Gravitt PE; Steiniche T; Petersen LK; Hammer A
    BMJ Open; 2022 Jul; 12(7):e059593. PubMed ID: 35793925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome.
    Branca M; Ciotti M; Santini D; Di Bonito L; Giorgi C; Benedetto A; Paba P; Favalli C; Costa S; Agarossi A; Alderisio M; Syrjänen K
    Int J Gynecol Pathol; 2004 Oct; 23(4):354-65. PubMed ID: 15381905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
    Li Y; Liu J; Gong L; Sun X; Long W
    Virol J; 2019 Oct; 16(1):117. PubMed ID: 31619262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles.
    Tian R; Cui Z; He D; Tian X; Gao Q; Ma X; Yang JR; Wu J; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Zhong H; Fan W; Chen Y; Jin Z; Cao C; Yu M; Xie W; Huang Z; Bao Y; Xie H; Yao S; Hu Z
    Carcinogenesis; 2019 Oct; 40(10):1220-1228. PubMed ID: 31102403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer.
    Kanthiya K; Khunnarong J; Tangjitgamol S; Puripat N; Tanvanich S
    Asian Pac J Cancer Prev; 2016; 17(7):3201-6. PubMed ID: 27509952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
    Kumar R; Mandal S; Arora P; Mala YM; Khurana N
    J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.